Expression of neuropeptides on human epidermal Langerhans cells.
Staniek
V
V
Unité INSERM 346, Clinique Dermatologique, Hopital Edouard Herriot, Lyon.
Misery
L
L
Dezutter-Dambuyant
C
C
Claudy
A
A
Schmitt
D
D
D000328:Adult; D018949:Antigens, CD1 / Q000378:metabolism; D000078404:Epidermal Cells; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D007801:Langerhans Cells / Q000276:immunology / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D015213:Neuroimmunomodulation; D009478:Neuropeptide Y / Q000378:metabolism; D009479:Neuropeptides / Q000378:metabolism*; D009496:Neurotensin / Q000378:metabolism; D018004:Receptors, Bombesin / Q000378:metabolism; D017475:Receptors, Nerve Growth Factor / Q000378:metabolism; D013373:Substance P / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism
D018949:Antigens, CD1; D009478:Neuropeptide Y; D009479:Neuropeptides; D018004:Receptors, Bombesin; D017475:Receptors, Nerve Growth Factor; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D009496:Neurotensin